No Data
No Data
Nephros Shares 2024 Corporate Outlook and Plans
Benchmark Co. Maintains Nephros(NEPH.US) With Buy Rating, Maintains Target Price $5
One Forecaster Is Now More Bearish On Nephros, Inc. (NASDAQ:NEPH) Than They Used To Be
The Nephros, Inc. (NASDAQ:NEPH) Analyst Just Cut Their Revenue Forecast By 15%
US$4.75 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results
Earnings Call Summary | Nephros(NEPH.US) Q2 2024 Earnings Conference
No Data
No Data